2009-03-01Zeitschriftenartikel DOI: 10.1086/597006
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients
Background: Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency virus (HIV)–infected patients, and adequate immunogenicity and safety are of concern in this population. Methods: In the Swiss HIV Cohort Study, we identified 102 patients who received 17DV while they were HIV infected. We analyzed neutralization titers (NTs) after 17DV administration using the plaque reduction neutralization test. NTs of 1:10 were defined as reactive, and those of 1:
No license information
Show related Items with similar Title, Author, Creator or Subject.
2012-12-26ZeitschriftenartikelBiological and Phylogenetic Characteristics of Yellow Fever Virus Lineages from West Africa Stock, Nina K.; Laraway, Hewád; Faye, Ousmane; Diallo, Mawlouth; Niedrig, Matthias; Sall, Amadou A.The yellow fever virus (YFV), the first proven human-pathogenic virus, although isolated in 1927, is still a major public health problem, especially in West Africa where it causes outbreaks every year. Nevertheless, little ...
2010-11-24ZeitschriftenartikelDetection of yellow fever 17D genome in urine Domingo, Cristina; Yactayo, Sergio; Agbenu, Edinam; Demanou, Maurice; Schulz, Axel R.; Daskalow, Katjana; Niedrig, Matthias
2012-05-03ZeitschriftenartikelFirst International External Quality Assessment Study on Molecular and Serological Methods for Yellow Fever Diagnosis Domingo, Cristina; Escadafal, Camille; Rumer, Leonid; Méndez, Jairo A.; García, Paquita; Sall, Amadou A.; Teichmann, Anette; Mantke, Oliver Donoso; Niedrig, MatthiasObjective: We describe an external quality assurance (EQA) study designed to assess the efficiency and accurateness of molecular and serological methods used by expert laboratories performing YF diagnosis. Study Design: ...